Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
- PMID: 40537438
- PMCID: PMC12179452
- DOI: 10.1177/09636897251346599
Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy
Abstract
Adipocyte dysfunction plays a critical role in the pathogenesis of metabolic diseases, including type 2 diabetes (T2D). Human induced pluripotent stem cells (hiPSCs) offer a powerful platform for generating white, beige, and brown adipocytes, supporting both disease modeling and therapeutic research. This review provides a comprehensive summary of current differentiation methods to produce three functionally mature adipocyte types from pluripotent stem cells (PSCs), including forced gene expression techniques, developmental biology-inspired approaches, and advanced three-dimensional (3D) culture systems that enhance cellular maturity and functional relevance. PSC-derived white adipocytes contribute to modeling adipocyte dysfunction not only in conditions such as insulin resistance, lipodystrophy, and premature aging but also in more complex metabolic diseases, including T2D, facilitating the investigation of disease mechanisms and the identification of novel therapeutic targets. In addition, iPSC-based models provide a robust platform for exploring genetic regulation by genome-wide association studies (GWAS)-identified variants through population genetics. This review also evaluates the therapeutic potential of iPSC-derived white, beige, and brown adipocytes in cell transplantation therapy for metabolic diseases, with a focus on engraftment potential and metabolic improvement. Enhancing the maturity and subtype specificity of PSC-derived adipocytes is expected to accelerate the development of personalized medicine and innovative therapeutic strategies for metabolic diseases.
Keywords: beige adipocytes; brown adipocytes; pluripotent stem cells; transplantation; white adipocytes.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures


Similar articles
-
CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease.Nat Commun. 2021 Nov 26;12(1):6931. doi: 10.1038/s41467-021-27190-y. Nat Commun. 2021. PMID: 34836963 Free PMC article.
-
An epigenome atlas of mouse adipocytes.Mol Metab. 2025 Sep;99:102197. doi: 10.1016/j.molmet.2025.102197. Epub 2025 Jun 27. Mol Metab. 2025. PMID: 40582590 Free PMC article.
-
[Pachymic acid promotes brown/beige adipocyte differentiation and lipid metabolism in preadipocytes].Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025 May 25;54(3):333-341. doi: 10.3724/zdxbyxb-2024-0355. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2025. PMID: 39807020 Free PMC article. Chinese.
-
Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review.Cells. 2025 Aug 1;14(15):1188. doi: 10.3390/cells14151188. Cells. 2025. PMID: 40801620 Free PMC article. Review.
-
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2. Cochrane Database Syst Rev. 2022. PMID: 35556242 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical